Objective: To provide references for microbiological risk control of preparations of medical institutions. Methods: The process of investigating the microorganism risk of potassium citrate solution was retrospectively analyzed. The effects of microbial limit test after improvement were explored. Resuults: Terminal sterilization by adding coloring agent (5% tartrazine solution) could ensure the microbial limit of potassium citrate solution. Conclusion: Terminal sterilization for coloring agent was an effective way to ensure the microbial limit of potassium citrate solution.
Key words
potassium citrate solution; microorganism; risk control; improvement; effects
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 中华人民共和国卫生部药政局.《中国医院制剂规范(第一版)》[M]. 天津:天津科技翻译出版公司,1989:7-9.
[2] 中华人民共和国卫生部药政局.《中国医院制剂规范(西药制剂第二版)》[M]. 北京:中国医药科技出版社,1995:7-8.
[3] 中国人民解放军总后勤部卫生部. 中国人民解放军医疗机构制剂规范[M]. 北京:人民军医出版社,1987:85-85.
[4] 北京市卫生局.医疗单位制剂规程[M]. 北京:1984:23-24.
[5] 北京市食品药品监督管理局. 北京市医疗机构制剂规程(2014年版第一册)[M]. 北京:中国商业出版社, 2014:94-95.
[6] 胡昌勤.药品微生物控制现状与展望[J].中国药学杂志, 2015,50(20):1747-1751.
[7] 李嘉,王彪,杜小莉,等. 2013年我院制剂价格调整前后的临床使用分析[J].中国药师,2016,19(8):1546-1548.
[8] 高捷,范义凤,李丽,等.枸橼酸钾溶液微生物限度检查法验证实验[J].现代医药卫生,2008,24(11):1716-1717.
{{custom_fnGroup.title_en}}
Footnotes
{{custom_fn.content}}